NMPA-2021-0004-V404

Type IA variation for application NMPA-2021-0004. Type IA variation: Formulation Change for Glucovantib — critical change

Variation Number
NMPA-2021-0004-V404
Type
Type IA
Application
NMPA-2021-0004
Change
CHG-2021-0104
Status
Overdue
Fee
€1,890
Submitted
—
Approved
—
Description

Type IA variation: Formulation Change for Glucovantib — critical change